Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Deconinck

Showing results (231-240 of 236) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 236 results.
Leukemia|March 1, 2020
CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasmElodie Bôle-Richard, Maxime Fredon, Sabeha Biichlé, et al.
Bulletin Du Cancer|September 12, 2024
[Nurturing and growing a community of department heads: Act 2 in haematology]Roch Houot, Claire Calmettes, Sophie Park, et al.
Haematologica|May 13, 2022
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantationAnnalisa Ruggeri, Liesbeth C De Wreede, Carlheinz R Müller, et al.
Haematologica|October 15, 2020
Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscapeLoria Zalmaï, Pierre-Julien Viailly, Sabeha Biichle, et al.
Leukemia|January 23, 2021
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trialFrancois Guilhot, Françoise Rigal-Huguet, Joëlle Guilhot, et al.
Blood Advances|December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Pageof 24

Showing results (231-240 of 236) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 236 results.
Leukemia|March 1, 2020
CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasmElodie Bôle-Richard, Maxime Fredon, Sabeha Biichlé, et al.
Bulletin Du Cancer|September 12, 2024
[Nurturing and growing a community of department heads: Act 2 in haematology]Roch Houot, Claire Calmettes, Sophie Park, et al.
Haematologica|May 13, 2022
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantationAnnalisa Ruggeri, Liesbeth C De Wreede, Carlheinz R Müller, et al.
Haematologica|October 15, 2020
Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscapeLoria Zalmaï, Pierre-Julien Viailly, Sabeha Biichle, et al.
Leukemia|January 23, 2021
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trialFrancois Guilhot, Françoise Rigal-Huguet, Joëlle Guilhot, et al.
Blood Advances|December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Pageof 24